Glaucoma medications may be associated with reduced risk of death over 4-year periodFebruary 09, 2010Glaucoma patients who take medication for the condition appear to have a reduced likelihood of death, according to a report in the February issue of Archives of Ophthalmology, one of the JAMA/Archives journals. Glaucoma (a common condition that consists of elevated pressure in the eye, and that can lead to loss of vision) usually affects older adults, who are at risk for co-existing medical conditions that can negatively affect their survival, according to background information in the article. "In recent years, numerous studies have assessed whether glaucoma is associated with mortality," the authors write. "Few studies, however, have considered whether the medications commonly used to treat glaucoma may affect the association between glaucoma and death." Joshua D. Stein, M.D., M.S., and colleagues at the University of Michigan, Ann Arbor, conducted a study evaluating the relationship between glaucoma medication use and death in 21,506 individuals age 40 or older (average age 60) with glaucoma or suspected glaucoma from January 2003 to December 2007 who were enrolled in a large managed care network. Glaucoma medication use was defined as filling one or more prescriptions for a 30-day or more supply of the drug during the study period. Deaths were reported by family members, employers or health care professionals and other demographic information was noted at the beginning of the study. More than half of the patients had suspected glaucoma, the others had one or more types of glaucoma. "During the study period, 6,049 beneficiaries (28.1 percent) filled one or more prescriptions for a glaucoma medication; 2,021 individuals (9.4 percent) underwent glaucoma surgery," the authors write. Of the 21,506 patients, 237 (1.1 percent) died during the study. When compared to those with no glaucoma medication use, those using any class of glaucoma medication had a 74 percent reduced risk of death. "This association was observed for use of a single agent alone, such as a topical beta-antagonist or a prostaglandin analogue, and for use of different combinations of drug classes," the authors write. "Additional studies are needed to determine whether this result is best explained by a protective effect of the medications themselves or by other confounding factors, such as access to care or providers' prescribing patterns," the authors conclude. "Future investigations should explore this association further because these findings may have important clinical implications." JAMA and Archives Journals |
|||||||||||||||||||||
| Related Glaucoma Current Events and Glaucoma News Articles K-State professor finds link between low oxygen levels in body and cancer-aiding protein What began as research into how diabetics could possibly preserve their eyesight has led to findings that could prolong the vision of children afflicted with retinoblastoma. Untreated poor vision in elderly linked to dementia, University of Michigan study shows Elderly people with visual disorders that are left untreated are significantly more likely to develop Alzheimer's disease -- the most common form of dementia, according to a University of Michigan Health System study. New evidence that green tea may help fight glaucoma and other eye diseases Scientists have confirmed that the healthful substances found in green tea - renowned for their powerful antioxidant and disease-fighting properties - do penetrate into tissues of the eye. Millimeter-scale, energy-harvesting sensor system developed A 9 cubic millimeter solar-powered sensor system developed at the University of Michigan is the smallest that can harvest energy from its surroundings to operate nearly perpetually. Double agent: Glial cells can protect or kill neurons, vision Scientists have identified a double agent in the eye that, once triggered, can morph from neuron protector to neuron killer. The discovery has significant health implications since the neurons killed through this process results in vision loss and blindness. UK Study Advances New Target for CNS Drug Development A breakthrough discovery by scientists at the University of Kentucky could someday lead to new treatments for a variety of diseases of the brain, spinal cord and the eye. Seeing a diagnosis: How an eye test could aid Alzheimer's detection A simple and inexpensive eye test could aid detection and diagnosis of major neurological diseases such as Alzheimer's at an earlier stage than is currently possible, according to new research by UCL scientists. Study explains why light worsens migraine headaches Ask anyone who suffers from migraine headaches what they do when they're having an attack, and you're likely to hear "go into a dark room." And although it's long been known that light makes migraines worse, the reason why has been unclear. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. Cataract surgery helps AMD patients; steroid improves DME; online eye health forum This month's Ophthalmology, the journal of the American Academy of Ophthalmology (Academy) reports on a national study that finds cataract surgery is likely to benefit patients with age-related macular degeneration (AMD) at all stages of the disease, on a clinical trial showing that the steroid triamcinolone may be effective in advanced diabetic macular edema (DME) patients when standard treatment fails, and on the public's use of two Academy-sponsored online eye health forums. More Glaucoma Current Events and Glaucoma News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||